MarketInOut Stock Screener Log In | Sign Up

Lakewood-Amedex Biotherapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Lakewood-Amedex Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization0.5038 mln
Float1.58 mln

Piotroski F-Score

1 / 9
Very weak

1-Year Forecast

7.50
Transformational upside

Relative Strength

0 / 100
Severely lagging

Debt / Equity

0.02
Debt-free

ROE

-403
Deeply negative

ROA

-449
Deeply negative

Business Description

Lakewood-Amedex Biotherapeutics Inc. is a Florida-based company focused on creating new medicines to fight bacterial infections. Its lead group of treatments, called Bisphosphocins, targets a wide range of infections in areas such as the skin, bladder, and lungs. The company is currently running a mid-stage clinical trial for Nu-3, a topical treatment designed to address infected foot wounds in diabetic patients.

Key Fundamentals

EPS-8.83
ROE-403
ROIC-388
ROA-449
Interest Cover-58.40
EBITDA, mln-7.10
EV / EBITDA0.54
EV / EBIT0.53

Quote Details

Last 0.20
Change -0.0373 (-15.72%)
Open 0.197
Volume 1,449,050
Turnover 289,810
Average Volume 2,916,174

Financial Ratios

Leverage Ratio1.15
Current Ratio7.70
Price / Book0.14
Price / Tangible Book0.14
Debt / Equity0.02

Financial Strength

Piotroski F-Score 1 / 9
1-Year Target Price7.50
Short Ratio0.04
Short % of Float7.39

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -35.48% 1 / 100   
1 Month -78.5% 1 / 100   
2 Months -92% 1 / 100   
6 Months -99.42% 0 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog